- $125.56m
- $112.83m
- $53.20m
- 88
- 36
- 79
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 14.4 | 16.4 | 28.1 | 37.6 | 53.2 |
Cost of Revenue | |||||
Gross Profit | 10.1 | 11.4 | 21.5 | 29.2 | 37.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13.3 | 14.4 | 30.9 | 74.9 | 54.9 |
Operating Profit | 1.14 | 2 | -2.81 | -37.4 | -1.69 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.15 | 1.9 | -2.91 | -36.2 | -0.264 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.14 | 7.94 | -2.44 | -35.4 | -0.362 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.14 | 7.94 | -2.44 | -35.4 | -0.362 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.14 | 7.94 | -2.44 | -35.4 | -0.362 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.073 | 0.418 | -0.087 | -0.616 | -0.05 |
Dividends per Share |